Sullivan and Satel offer a nuanced view of physician-industry relationships. Sullivan makes this point, with which I partially disagree:
For now, there is no data suggesting any harm to patients from working with industry because no studies have used clinical outcomes.
It's true that there are no data suggesting harm to patients from working with industry. The pharmascolds have no data in support of their position. All they can do is appeal to a set of popular beliefs. What I disagree with is the statement that no studies have looked at clinical outcomes. One study did look at clinical outcomes following an industry sponsored campaign. I've blogged about it extensively before. One of the most maligned Pharma campaigns in all of medicine resulted in improved outcomes, even reduced mortality, in septic patients.